Is federal marijuana rescheduling good for Big Pharma?
With rescheduling, investors and financial institutions that worried about the stigma surrounding marijuana are taking another look.
News April 30
Latest In: cultivation
How cannabis MSO TerrAscend is responding to federal marijuana rescheduling
TerrAscend will leverage federal rescheduling of medical cannabis to drive growth, shape policy with a focus on compliance…
News April 30
Florida spars with cannabis MSO Trulieve over alleged pollution at cultivation site
The violations include unpermitted impervious surfaces, standing water in stormwater ponds and erosion caused by prolonged water discharge.
News April 28
Should cannabis remediated with radiation be labeled?
Maine regulations require that cannabis treated with irradiation must be labeled as such, but regulators have not enforced…
News April 27
AI and robotics are taking over the cannabis industry. Are they replacing jobs?
Automation and AI can help with growing plants and selling products, raising questions about what happens to the…
News April 27
How does marijuana rescheduling affect cannabis companies now?
Some operators are seeking partnerships for clinical studies, while others are developing strategies to scale their operations.
News April 23
Mr. Sherbinski speaks: From medical cannabis to Gelato, hot strains rule the game
OG Kush ruled the roost in the medical cannabis era before candy flavors seized control during early legalization.…
March 31
How higher education is embracing legal cannabis
Cannabis education is no longer a niche offering – schools nationwide offer courses designed for careers in the…
News March 30
Cannabis MSO PharmaCann closes another cultivation facility
Both facilities are slated to close on May 20. In Pennsylvania, 60 people will lose their jobs; in…
News March 25Featured
1
Latest Sponsored
